Home  »  Company  »  Marksans Pharma Ltd.  »  Quotes  »  Audited Results
Enter the first few characters of Company and click 'Go'

Audited Results of Marksans Pharma Ltd. Company

(Rs in Cr.) Mar 31, 2023 Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019
Operating Income 655.20 658.29 599.55 433.42 424.16
Manufacturing Expenses 14.24 11.27 10.90 8.95 8.22
Personnel Expenses 56.09 60.46 54.64 48.51 46.33
Selling Expenses 0 0 0 0 0
Administrative Expenses 98.52 95.25 82.38 61.43 69.94
Expenses Capitalised 0 0 0 0 0
Cost Of Sales 563.30 544.57 485.84 361.93 360.83
Operating Profit 91.90 113.72 113.71 71.49 63.33
Other Recurring Income 60.48 42.25 31.16 0.17 7.93
Adjusted PBDIT 152.38 155.97 144.87 71.66 71.26
Financial Expenses 3.61 3.79 5.34 7.29 6.56
Depreciation 16.74 17.66 15.19 11.64 8.69
Other Write offs 0 0 0 0 0
Adjusted PBT 132.03 134.51 124.33 52.73 56.01
Tax Charges 29.17 30.52 25.95 14.82 12.39
Adjusted PAT 102.87 103.99 98.38 37.90 43.62
Non Recurring Items -0.59 0.05 -0.20 0.16 0.03
Other Non Cash adjustments 0 0 0 0 0
Reported Net Profit 102.87 103.99 98.38 37.90 43.62
Equity Dividend 10.17 10.23 4.09 2.47 2.05
Preference Dividend 0 0 0 0 0
Retained Earnings 247.31 155.21 61.41 -27.14 -62.74
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X